Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223
Dr. Noel W. Clarke presented “Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab,...
Read MoreSelect Page
Posted by Noel Clarke, MBBS, FRCS, ChM | Mar 2017
Dr. Noel W. Clarke presented “Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab,...
Read MorePosted by Nicolas Mottet, MD, PhD | Feb 2017
Dr. Nicolas Mottet presented “Managing Prostate Cancer in Elderly/Unfit Patients” at the 6th...
Read MorePosted by Noel Clarke, MBBS, FRCS, ChM | Feb 2017
Dr. Noel W. Clarke presented “Combination Therapy in Hormone-Sensitive Prostate Cancer” at the...
Read MorePosted by Nicolas Mottet, MD, PhD | Feb 2017
Dr. Nicolas Mottet presented “EAU Guidelines for Monitoring Prostate Cancer Patients Under Treatment” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between October 14th and 16th 2016.
Read MorePosted by Martin Spahn, MD | Feb 2017
Dr. Martin Spahn presented “Next Generation Sequencing of Prostate Tumors: Use of Individualized...
Read More